338 related articles for article (PubMed ID: 26434196)
1. [DRUG THERAPY OF NEUROPATHIC PAIN BASED ON THE LATEST RECOMMENDATIONS].
Kiss G
Ideggyogy Sz; 2015 Mar; 68(3-4):93-8. PubMed ID: 26434196
[TBL] [Abstract][Full Text] [Related]
2. Clinical inquiry: what medications are best for diabetic neuropathic pain?
Page N; Deluca J; Crowell K
J Fam Pract; 2012 Nov; 61(11):691-3. PubMed ID: 23256101
[TBL] [Abstract][Full Text] [Related]
3. [Neuropathic pain in oncology. Novel evidence for clinical practice].
Tassinari D; Drudi F; Carloni F; Possenti C; Santelmo C; Castellani C
Recenti Prog Med; 2011 May; 102(5):220-7. PubMed ID: 21607008
[TBL] [Abstract][Full Text] [Related]
4. Treatment of neuropathic pain: an overview of recent guidelines.
O'Connor AB; Dworkin RH
Am J Med; 2009 Oct; 122(10 Suppl):S22-32. PubMed ID: 19801049
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.
Dworkin RH; O'Connor AB; Audette J; Baron R; Gourlay GK; Haanpää ML; Kent JL; Krane EJ; Lebel AA; Levy RM; Mackey SC; Mayer J; Miaskowski C; Raja SN; Rice AS; Schmader KE; Stacey B; Stanos S; Treede RD; Turk DC; Walco GA; Wells CD
Mayo Clin Proc; 2010 Mar; 85(3 Suppl):S3-14. PubMed ID: 20194146
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
[TBL] [Abstract][Full Text] [Related]
7. Review of current guidelines on the care of postherpetic neuralgia.
Argoff CE
Postgrad Med; 2011 Sep; 123(5):134-42. PubMed ID: 21904096
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model.
Miyazaki R; Yamamoto T
Anesth Analg; 2012 Jul; 115(1):182-8. PubMed ID: 22415534
[TBL] [Abstract][Full Text] [Related]
9. Career lifetime advances and key developments: diabetes.
Baglioni P; Govindan J; Khan A
Clin Med (Lond); 2007 Jun; 7(3):303-4. PubMed ID: 17639617
[No Abstract] [Full Text] [Related]
10. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
[TBL] [Abstract][Full Text] [Related]
11. [Neuropathic pain in children].
Fournier-Charrière E
Arch Pediatr; 2010 Jun; 17(6):665-6. PubMed ID: 20654832
[No Abstract] [Full Text] [Related]
12. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
Choy E; Richards S; Bowrin K; Watson P; Lloyd A; Sadosky A; Zlateva G
Curr Med Res Opin; 2010 Apr; 26(4):965-75. PubMed ID: 20178405
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK.
Beard SM; McCrink L; Le TK; Garcia-Cebrian A; Monz B; Malik RA
Curr Med Res Opin; 2008 Feb; 24(2):385-99. PubMed ID: 18157921
[TBL] [Abstract][Full Text] [Related]
14. Interventions for Neuropathic Pain: An Overview of Systematic Reviews.
Dosenovic S; Jelicic Kadic A; Miljanovic M; Biocic M; Boric K; Cavar M; Markovina N; Vucic K; Puljak L
Anesth Analg; 2017 Aug; 125(2):643-652. PubMed ID: 28731977
[TBL] [Abstract][Full Text] [Related]
15. Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
Terneus W
J Pain Palliat Care Pharmacother; 2007; 21(1):79-84. PubMed ID: 17430838
[TBL] [Abstract][Full Text] [Related]
16. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
Gore M; Sadosky A; Tai KS; Stacey B
Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of the development of neuropathic pain and its treatment].
Yamamoto T
Nihon Hansenbyo Gakkai Zasshi; 2008 Sep; 77(3):215-8. PubMed ID: 18800643
[TBL] [Abstract][Full Text] [Related]
18. Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine.
Arai YC; Matsubara T; Shimo K; Suetomi K; Nishihara M; Ushida T; Kobayashi K; Suzuki C; Kinoshita A; Kondo M; Matsubara S; Hayashi R; Tohyama Y; Nishida K; Arakawa M
J Anesth; 2010 Jun; 24(3):407-10. PubMed ID: 20217150
[TBL] [Abstract][Full Text] [Related]
19. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology.
Dubinsky RM; Kabbani H; El-Chami Z; Boutwell C; Ali H;
Neurology; 2004 Sep; 63(6):959-65. PubMed ID: 15452284
[TBL] [Abstract][Full Text] [Related]
20. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.
Attal N; Cruccu G; Baron R; Haanpää M; Hansson P; Jensen TS; Nurmikko T
Eur J Neurol; 2010 Sep; 17(9):1113-e88. PubMed ID: 20402746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
